1. Academic Validation
  2. Tripartite motif containing 26 prevents steatohepatitis progression by suppressing C/EBPδ signalling activation

Tripartite motif containing 26 prevents steatohepatitis progression by suppressing C/EBPδ signalling activation

  • Nat Commun. 2023 Oct 11;14(1):6384. doi: 10.1038/s41467-023-42040-9.
Minxuan Xu # 1 2 Jun Tan # 3 Xin Liu # 4 Li Han # 4 Chenxu Ge # 5 6 Yujie Zhang 5 Fufang Luo 5 Zhongqin Wang 5 Xiaoqin Xue 5 Liangyin Xiong 5 Xin Wang 5 Qinqin Zhang 5 Xiaoxin Wang 5 Qin Tian 5 Shuguang Zhang 4 Qingkun Meng 7 Xianling Dai 5 6 Qin Kuang 5 6 Qiang Li 5 Deshuai Lou 5 Linfeng Hu 5 6 Xi Liu 5 Gang Kuang 5 Jing Luo 5 Chunxiao Chang 7 Bochu Wang 6 Jie Chai 7 Shengbin Shi 8 Lianyi Han 9
Affiliations

Affiliations

  • 1 Chongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, 400067, Chongqing, P. R. China. minxuanxu@foxmail.com.
  • 2 Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education, College of Bioengineering, Chongqing University, 400030, Chongqing, P. R. China. minxuanxu@foxmail.com.
  • 3 Chongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, 400067, Chongqing, P. R. China. tanjun@cque.edu.cn.
  • 4 Department of Gastrointestinal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Science, 250117, Jinan, P. R. China.
  • 5 Chongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education, 400067, Chongqing, P. R. China.
  • 6 Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education, College of Bioengineering, Chongqing University, 400030, Chongqing, P. R. China.
  • 7 Geriatrics Department, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 250117, Jinan, P. R. China.
  • 8 New Drug Technology R&D Center, Nanjing Biomed Sciences Inc., 210003, Nanjing, P. R. China. shisb_njbms@yeah.net.
  • 9 Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, 315211, Shanghai, China. hanlianyi@fudan.edu.cn.
  • # Contributed equally.
Abstract

Currently potential preclinical drugs for the treatment of nonalcoholic steatohepatitis (NASH) and NASH-related pathopoiesis have failed to achieve expected therapeutic efficacy due to the complexity of the pathogenic mechanisms. Here we show Tripartite motif containing 26 (TRIM26) as a critical endogenous suppressor of CCAAT/enhancer binding protein delta (C/EBPδ), and we also confirm that TRIM26 is an C/EBPδ-interacting partner protein that catalyses the ubiquitination degradation of C/EBPδ in hepatocytes. Hepatocyte-specific loss of Trim26 disrupts liver metabolic homeostasis, followed by glucose metabolic disorder, lipid accumulation, increased hepatic inflammation, and fibrosis, and dramatically facilitates NASH-related phenotype progression. Inversely, transgenic Trim26 overexpression attenuates the NASH-associated phenotype in a rodent or rabbit model. We provide mechanistic evidence that, in response to metabolic insults, TRIM26 directly interacts with C/EBPδ and promotes its ubiquitin Proteasome degradation. Taken together, our present findings identify TRIM26 as a key suppressor over the course of NASH development.

Figures
Products